Hanson & Doremus Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Buy |
570
+200
| +54% | +$89.1K | 0.03% | 176 |
|
|
2025
Q1 | $179K | Buy |
370
+300
| +429% | +$145K | 0.03% | 197 |
|
|
2024
Q4 | $28K | Hold |
70
| – | – | ﹤0.01% | 346 |
|
|
2024
Q3 | $33K | Hold |
70
| – | – | 0.01% | 331 |
|
|
2024
Q2 | $33K | Hold |
70
| – | – | 0.01% | 330 |
|
|
2024
Q1 | $29K | Hold |
70
| – | – | 0.01% | 343 |
|
|
2023
Q4 | $28K | Sell |
70
-5
| -7% | -$2K | 0.01% | 340 |
|
|
2023
Q3 | $26K | Hold |
75
| – | – | 0.01% | 337 |
|
|
2023
Q2 | $26K | Hold |
75
| – | – | 0.01% | 343 |
|
|
2023
Q1 | $24K | Hold |
75
| – | – | 0.01% | 360 |
|
|
2022
Q4 | $22K | Hold |
75
| – | – | ﹤0.01% | 393 |
|
|
2022
Q3 | $22K | Buy |
+75
| New | +$22K | 0.01% | 374 |
|
|
2021
Q2 | – | Sell |
-7
| Closed | -$2K | – | 531 |
|
|
2021
Q1 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 491 |
|